Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Metrics Regulatory News (OMG)

Share Price Information for Oxford Metrics (OMG)

Share Price is delayed by 15 minutes
Get Live Data
46.00    -2.00 (-4.17%)
Bid:
46.10
Ask:
47.90
Spread: 1.80 (3.905%)
Market Cap: £51.49m
OMG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Metrics Share Chart

Change in Accounting Reference Date

16 Dec 2025 10:48

RNS Number : 7797L
Oxford Metrics PLC
16 December 2025
 

16 December 2025

Oxford Metrics plc ("Oxford Metrics", the "Company" or the "Group")

 

Change in Accounting Reference Date

 

Oxford Metrics plc (LSE: OMG), the smart sensing and software company servicing life sciences, entertainment, engineering and smart manufacturing markets, announces that the Company intends to change to its accounting reference date and financial year end from 30 September to 31 December with immediate effect. As announced in the Company's preliminary results on 9 December 2025, the business activities and revenues of the Group are weighted toward the final third of the calendar year. To aid the Group in the orderly preparation of its financial statements, the Directors consider that presenting financial statements that have a more balanced first half and second half weighting is in the best interests of the Group.

 

The Group's next financial year will now end on 31 December 2026.

 

As a result of this change, the Group's financial year will now end on 31 December annually, with its reporting timetable as follows:

 

·

publication of unaudited interim accounts for the 6-month period to 31 March 2026, by no later than 30 June 2026;

·

publication of unaudited interim accounts for the 12-month period to 30 September 2026, by no later than 31 December 2026;

·

publication of audited annual financial statements for the 15-month period to 31 December 2026, by no later than 30 June 2027;

·

publication of unaudited interim accounts for the 6-month period to 30 June 2027, by no later than 30 September 2027; and

·

publication of audited annual financial statements for the 12-month period to 31 December 2027, by no later than 30 June 2028, and in respect of each subsequent 12-month periods thereafter.

 

For more information, please contact:

 

Oxford Metrics plc

+44 (0) 18 6526 1860

Imogen O'Connor, CEOZoe Fox, CFO

 

 

Panmure Liberum (Nomad and Broker)

+44 (0) 20 3100 2000

James Sinclair-Ford / Rupert Dearden /Gaya Bhatt

 

 

Alma Strategic Communications

+44 (0) 20 3405 0205

Hilary Buchanan / Rebecca Sanders-HewettDavid Ison / Kinvara Verdon

oxfordmetrics@almastrategic.com

 

About Oxford Metrics

 

Oxford Metrics (LSE:OMG) is a smart sensing and measurement technology Group that serves thousands of customers in more than 70 countries. Founded in 1984, we started our journey in healthcare, expanded into entertainment, winning an OSCAR® and an Emmy®, moved into engineering and more recently, smart manufacturing. We have a strong track record of creating value by incubating, growing and then augmenting through acquisition, unique technology businesses.

 

The Group trades through two divisions; in motion capture its market-leading company Vicon Motion Systems provides motion measurement analysis to thousands of customers worldwide in healthcare, entertainment and engineering markets. In Smart Manufacturing, Industrial Vision Systems is a specialist in machine vision software and technology for high precision, automated quality control systems trusted by blue-chip, smart manufacturing companies in medical devices, pharmaceuticals and performance engineering. Sempre is a measurement specialist solving manufacturing challenges across aerospace, automotive, medical device, and precision engineering markets.

 

The Group is headquartered in Oxford with offices in the United Kingdom, Ireland, United States and Germany.

 

For more information about Oxford Metrics, visit www.oxfordmetrics.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NARFFMFSMEISELE
Date   Source Headline
6th Jun 20237:00 amRNSInterim Results
25th May 202311:59 amRNSInvestor Presentation
17th May 20237:00 amRNSVicon contract win
12th May 20237:00 amRNSNotification of Results
13th Feb 20232:15 pmRNSPDMR Shareholding and Director Dealing
9th Feb 20232:59 pmRNSResult of AGM
9th Feb 20237:00 amRNSAGM Statement
17th Jan 202311:22 amRNSPDMR Shareholding, Issue of Ordinary Shares & TVR
22nd Dec 20227:00 amRNSDividend update
16th Dec 202211:39 amRNSIssue of Ordinary Shares & Total Voting Rights
13th Dec 20225:51 pmRNSPosting Annual Report & Accounts and Notice of AGM
9th Dec 202211:20 amRNSPDMR Shareholding, Issue of Ordinary Shares & TVR
6th Dec 20225:06 pmRNSPDMR Shareholding, Issue of Ordinary Shares & TVR
6th Dec 20227:00 amRNSPreliminary Results
28th Nov 20227:00 amRNSInvestor Presentation
9th Nov 20227:00 amRNSNotice of Results
27th Sep 20227:00 amRNSTrading Update
17th Aug 20227:00 amRNSVicon Contract Win
28th Jul 202212:46 pmRNSIssue of Ordinary Shares & Total Voting Rights
20th Jul 20227:00 amRNSIssue of Ordinary Shares & Total Voting Rights
19th Jul 202212:42 pmRNSIssue of Ordinary Shares & Total Voting Rights
19th Jul 20227:00 amRNSVicon launches new Valkyrie solution
5th Jul 20225:04 pmRNSHolding(s) in Company
4th Jul 20225:53 pmRNSExercise of Options, Director Dealing and TVR
24th Jun 20227:00 amRNSIssue of Ordinary Shares & Total Voting Rights
23rd Jun 20227:00 amRNSInterim Results
7th Jun 20227:00 amRNSInvestor Presentation
6th Jun 20224:40 pmRNSSecond Price Monitoring Extn
6th Jun 20224:35 pmRNSPrice Monitoring Extension
31st May 20223:11 pmRNSHolding(s) in Company
31st May 202211:51 amRNSHolding(s) in Company
30th May 20224:40 pmRNSSecond Price Monitoring Extn
30th May 20224:35 pmRNSPrice Monitoring Extension
30th May 20227:00 amRNSSale of Yotta
17th May 20227:00 amRNSNotification of Results
9th Feb 20222:33 pmRNSResult of AGM
9th Feb 20222:00 pmRNSAnnual General Meeting Statement
12th Jan 20227:00 amRNSUpdate to Notice of 2022 AGM
10th Jan 20223:30 pmRNSIssue of Ordinary Shares & Total Voting Rights
13th Dec 20215:30 pmRNSPosting Annual Report & Accounts and Notice of AGM
9th Dec 20217:00 amRNSInvestor Presentation
6th Dec 20214:00 pmRNSPDMR Shareholding, Issue of Ordinary Shares & TVR
2nd Dec 20215:15 pmRNSGrant of LTIP Awards to Directors
2nd Dec 202112:45 pmRNSPDMR Shareholding, Issue of Ordinary Shares & TVR
2nd Dec 20217:00 amRNSPreliminary Results
27th Oct 202111:31 amRNSIssue of Ordinary Shares & Total Voting Rights
26th Oct 20217:00 amRNSVicon Contract Win
19th Oct 20217:00 amRNSTrading Statement and Capital Markets Day
1st Oct 20217:00 amRNSAppointment of Non-Executive Director
1st Sep 20217:00 amRNSAcquisition of CONTEMPLAS GmbH

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.